Paraneoplastic dermatological manifestation of gastrointestinal malignancies

World Journal of Gastroenterology

Volumn 15, Issue 35, 2009, Pages 4372-4379

  Dourmishev, Lyubomir A ^a   Draganov, Peter V ^b  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Cancer; Dermatological; Gastrointestinal; Malingnancy; Paraneoplastic

Indexed keywords

CAPECITABINE; CISPLATIN; EPIRUBICIN; FLUOROURACIL; OXALIPLATIN; PROTEIN KINASE LKB1; PROTEIN MLH1; PROTEIN MSH2; TRANSFORMING GROWTH FACTOR ALPHA RECEPTOR;

ACANTHOSIS NIGRICANS; AUTOSOMAL DOMINANT INHERITANCE; BAZEX SYNDROME; CANCER SCREENING; COLORECTAL CANCER; CRONKHITE CANADA SYNDROME; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; HUMAN; LABORATORY TEST; LESER TRELAT SYNDROME; LUNG METASTASIS; MUIR TORRE SYNDROME; PALMOPLANTAR KERATODERMA; PARANEOPLASTIC DERMATOMYOSITIS; PARANEOPLASTIC HYPERTRICHOSIS LANUGINOSA ACQUISITA; PARANEOPLASTIC PEMPHIGUS; PARANEOPLASTIC SYNDROME; PEUTZ JEGHERS SYNDROME; PHYSICAL EXAMINATION; PROGNOSIS; RECTUM CARCINOMA; REVIEW; SEBACEOUS CARCINOMA; SQUAMOUS CELL CARCINOMA; STOMACH ADENOCARCINOMA; SURVIVAL TIME;

EID: 72049131559     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.4372     Document Type: Review

References (86)

1. Andreev VC. Skin manifestations in visceral cancer. Curr Probl Dermatol 1978; 8: 1-168
2. Andreev VC. Acanthosis nigricans. Stomatologia 1963; 11: 5 (in Bulgarian)
3. Schwartz RA. Acanthosis nigricans. J Am Acad Dermatol 1994; 31: 1-19; quiz 20-22
4. Pentenero M, Carrozzo M, Pagano M, Gandolfo S. Oral acanthosis nigricans, tripe palms and sign of leser-trélat in a patient with gastric adenocarcinoma. Int J Dermatol 2004; 43: 530-532 (Pubitemid 39023043)
5. Nishidoi H, Koga S, Kanbe N. [Gastrointestinal carcinoma with skin diseases from the standpoint of surgery] Gan To Kagaku Ryoho 1988; 15: 1560-1563
6. Brown J, Winkelmann RK. Acanthosis nigricans: a study of 90 cases. Medicine (Baltimore) 1968; 47: 33-51
7. White H. Acanthosis nigricans and wart-like lesions associated with metastatic carcinoma of the stomach. Cutis 1976; 17: 931-933
8. Anderson SH, Hudson-Peacock M, Muller AF. Malignant acanthosis nigricans: potential role of chemotherapy. Br J Dermatol 1999; 141: 714-716 (Pubitemid 29512828)
9. Breathnach SM, Wells GC. Acanthosis palmaris: tripe palms. A distinctive pattern of palmar keratoderma frequently associated with internal malignancy. Clin Exp Dermatol 1980; 5: 181-189
10. Bazex A, Salvador R, Dupré A, Christol B. Syndrome paranéoplasique à type d'hyperkératose des extremités. Guérison après le traitement de ĺpithelioma laryngé. Bull Soc Fr Dermatol Syphiligr 1965; 72: 182
11. Bolognia JL. Bazex syndrome: acrokeratosis paraneoplastica. Semin Dermatol 1995; 14: 84-89
12. Estrela F, Pinto GM, Pinto LM, Afonso A. Acrokeratosis paraneoplastica (Bazex syndrome) with oropharyngeal squamous cell carcinoma. Cutis 1995; 55: 233-236
13. Votion V, Mineur P, Mirgaux M, Aupaix M. [Palmar and plantar hyperkeratosis associated with a gastric adenocarcinoma] Dermatologica 1982; 165: 660-663
14. Hsu YS, Lien GS, Lai HH, Cheng YS, Hu CH, Hsieh MC, Fang CL, Pan S. Acrokeratosis paraneoplastica (Bazex syndrome) with adenocarcinoma of the colon: report of a case and review of the literature. J Gastroenterol 2000; 35: 460-464 (Pubitemid 30427123)
15. Bolognia JL, Brewer YP, Cooper DL. Bazex syndrome (acrokeratosis paraneoplastica). An analytic review. Medicine (Baltimore) 1991; 70: 269-280
16. Leser E. Ueber ein die Krebskrankheit beim Menschen haufig begleitendes, noch wenig gekanntes Symptom. Munchener. Med Wochenschr 1901; 51: 2035-2036
17. Denucé M. A symptom of malignancy (symptom of Trélat' s noevi) applicable to the deep tumours of the abdomen and pelvis. Revue des maladies cancéreuses (Paris) 1899; 5: 146-156
18. Rampen HJ, Schwengle LE. The sign of Leser-Trélat: does it exist? J Am Acad Dermatol 1989; 21: 50-55
19. Dourmishev L. Multiple seborrheic keratoses associated with rectal adenocarcinoma. CEEDVA 2004; 6: 27-30
20. Schwartz RA, Helmold ME, Janniger CK, Gascon P. Sign of Leser-Trélat with a metastatic mucinous adenocarcinoma. Cutis 1991; 47: 258-260
21. Cohn MS, Classen RF. The sign of Leser-Trélat associated with adenocarcinoma of the rectum. Cutis 1993; 51: 255-257
22. Yeh JS, Munn SE, Plunkett TA, Harper PG, Hopster DJ, du Vivier AW. Coexistence of acanthosis nigricans and the sign of Leser-Trélat in a patient with gastric adenocarcinoma: a case report and literature review. J Am Acad Dermatol 2000; 42: 357-362
23. Kameya S, Noda A, Isobe E, Watanabe T. The sign of Leser-Trélat associated with carcinoma of the stomach. Am J Gastroenterol 1988; 83: 664-666 (Pubitemid 18157334)
24. Liddell K, White JE, Caldwell IW. Seborrhoeic keratoses and carcinoma of the large bowel. Three cases exhibiting the sign of Lester-Trélat. Br J Dermatol 1975; 92: 449-452
25. Hodak E, Halevy S, Ingber A, Engelstein D, Sandbank M. [Leser-Trélat sign in adenocarcinoma of the sigmoid colon - a rare clinical picture] Z Hautkr 1987; 62: 875-876
26. Heng MC, Soo-Hoo K, Levine S, Petresek D. Linear sebor rhei c keratoses as soc iated wi th under lying malignancy. J Am Acad Dermatol 1988; 18: 1316-1321
27. Bräuer J, Happle R, Gieler U, Effendy I. The sign of Lerser-Trélat: Fact and myth? J Eur Acad Dermatol Venereol 1992; 1: 77-80
28. Ginarte M, Sánchez-Aguilar D, Toribio J. Sign of Leser-Trélat associated with adenocarcinoma of the rectum. Eur J Dermatol 2001; 11: 251-253 (Pubitemid 32472681)
29. Tutakne MA, Das KD, Upadhyaya VK, Ramachandra S, Narayanaswamy AS, Sarkar SK. Leser Trelat sign associated with carcinoma of gastro-oesophageal junction. Indian J Cancer 1983; 20: 32-34
30. Klimopoulos S, Kounoudes C, Pantelidaki C, Skrepetou K, Papoudos M, Katsoulis H. The leser-trelat sign in association with carcinoma of the ampulla of Vater. Am J Gastroenterol 2001; 96: 1623-1626 (Pubitemid 32455102)
31. Ohashi N, Hidaka N. Pancreatic carcinoma associated with the Leser-Trélat sign. Int J Pancreatol 1997; 22: 155-160 (Pubitemid 27500572)
32. Kocyigit P, Akay BN, Arica E, Anadolu RY, Erdem C. Post-renal transplantation Leser-Trélat sign associated with carcinoma of the gallbladder: a rare association. Scand J Gastroenterol 2007; 42: 779-781 (Pubitemid 46763576)
33. Tajima H, Mitsuoka S, Ohtsuka E, Nakamura Y, Nakayama T, Satoh Y, Shima M, Nakata K, Kusumoto Y, Koji T. A case of hepatocellular carcinoma with the sign of Leser-Trelat: a possible role of a cutaneous marker for internal malignancy. Jpn J Med 1991; 30: 53-56
34. Holdiness MR. On the classification of the sign of Leser-Trélat. J Am Acad Dermatol 1988; 19: 754-757
35. Andreev VC, Boyanov L, Tsankov N. Generalized acanthosis nigricans. Dermatologica 1981; 163: 19-24
36. Ellis DL, Kafka SP, Chow JC, Nanney LB, Inman WH, McCadden ME, King LE Jr. Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trélat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. N Engl J Med 1987; 317: 1582-1587
37. Muir EG, Bell AJ, Barlow KA. Multiple primary carcinomata of the colon, duodenum, and larynx associated with keratoacanthomata of the face. Br J Surg 1967; 54: 191-195
38. Torre D. Multiple sebaceous tumors. Arch Dermatol 1968; 98: 549-551
39. Cohen PR, Kohn SR, Kurzrock R. Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med 1991; 90: 606-613
40. Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol 1995; 33: 90-104
41. Kruse R, Rütten A, Hosseiny-Malayeri HR, Bisceglia M, Friedl W, Propping P, Ruzicka T, Mangold E. "Second hit" in sebaceous tumors from Muir-Torre patients with germline mutations in MSH2: allele loss is not the preferred mode of inactivation. J Invest Dermatol 2001; 116: 463-465 (Pubitemid 32202914)
42. Lazar AJ, Lyle S, Calonje E. Sebaceous neoplasia and Torre-Muir syndrome. Curr Diagn Pathol 2007; 13: 301-319
43. Cohen PR. Sebaceous carcinomas of the ocular adnexa and the Muir-Torre syndrome. J Am Acad Dermatol 1992; 27: 279-280
44. Cohen PR, Kohn SR, Davis DA, Kurzrock R. Muir-Torre syndrome. Dermatol Clin 1995; 13: 79-89
45. Serleth HJ, Kisken WA. A Muir-Torre syndrome family. Am Surg 1998; 64: 365-369
46. Yanaba K, Nakagawa H, Takeda Y, Koyama N, Sugano K. Muir-Torre syndrome caused by partial duplication of MSH2 gene by Alu-mediat ed nonhomologous recombination. Br J Dermatol 2008; 158: 150-156 (Pubitemid 350221892)
47. Ponti G, Losi L, Di Gregorio C, Roncucci L, Pedroni M, Scarselli A, Benatti P, Seidenari S, Pellacani G, Lembo L, Rossi G, Marino M, Lucci-Cordisco E, Ponz de Leon M. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry. Cancer 2005; 103: 1018-1025 (Pubitemid 40270079)
48. Stertz G. Polymyositis. Berl Klin Wochenshr 1916; 53: 489
49. Dourmi shev LA, Dourmi shev AL, Schwar tz RA. Dermatomyositis: cutaneous manifestations of its variants. Int J Dermatol 2002; 41: 625-630
50. Santmyire-Rosenberger B, Dugan EM. Skin involvement in dermatomyositis. Curr Opin Rheumatol 2003; 15: 714-722
51. Kovacs SO, Kovacs SC. Dermatomyositis. J Am Acad Dermatol 1998; 39: 899-920; quiz 921-922
52. Targoff IN, Miller FW, Medsger TA Jr, Oddis CV. Classification criteria for the idiopathic inflammatory myopathies. Curr Opin Rheumatol 1997; 9: 527-535 (Pubitemid 27504210)
53. Sigurgeirsson B, Lindelöf B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 1992; 326: 363-367
54. Buchbinder R, Forbes A, Hall S, Dennett X, Giles G. Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med 2001; 134: 1087-1095 (Pubitemid 32552196)
55. Stockton D, Doherty VR, Brewster DH. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 2001; 85: 41-45 (Pubitemid 32695714)
56. Basset-Seguin N, Roujeau JC, Gherardi R, Guillaume JC, Revuz J, Touraine R. Prognostic factors and predictive signs of malignancy in adult dermatomyositis. A study of 32 cases. Arch Dermatol 1990; 126: 633-637 (Pubitemid 20157677)
57. Dourmishev LA. Dermatomyositis associated with malignancy. 12 case reports. Adv Exp Med Biol 1999; 455: 193-199
58. Chen YJ, Wu CY, Shen JL. Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study. Br J Dermatol 2001; 144: 825-831
59. Hatada T, Aoki I, Ikeda H, Tamura T, Okada K, Nakai T, Utsunomiya J. Dermatomyositis and malignancy: case report and review of the Japanese literature. Tumori 1996; 82: 273-275 (Pubitemid 26253726)
60. Leow YH, Goh CL. Malignancy in adult dermatomyositis. Int J Dermatol 1997; 36: 904-907
61. Wakata N, Kurihara T, Saito E, Kinoshita M. Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study. Int J Dermatol 2002; 41: 729-734 (Pubitemid 35422835)
62. Bajdekov B, Zlatkov N, Naumov V. Dermatomyositis as paraneoplastic disease. Oncology (Sofia) 1969; 6: 39-132 (in Bulgarian)
63. Dourmishev LA. Dermatomyositis: Current aspects. Sofia: PhD thesis, 2002: 140 (in Bulgarian)
64. Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M, Izumi H, Ratrie H 3rd, Mutasim D, Ariss-Abdo L. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990; 323: 1729-1735
65. Joly P, Richard C, Gilbert D, Courville P, Chosidow O, Roujeau JC, Beylot-Barry M, D'incan M, Martel P, Lauret P, Tron F. Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol 2000; 43: 619-626 (Pubitemid 30781511)
66. Anhalt GJ. Paraneoplastic pemphigus. J Investig Dermatol Symp Proc 2004; 9: 29-33
67. Stevens SR, Griffiths CE, Anhalt GJ, Cooper KD. Paraneoplastic pemphigus presenting as a lichen planus pemphigoides-like eruption. Arch Dermatol 1993; 129: 866-869 (Pubitemid 23206011)
68. Kaplan I, Hodak E, Ackerman L, Mimouni D, Anhalt GJ, Calderon S. Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations. Oral Oncol 2004; 40: 553-562 (Pubitemid 38452674)
69. Ostezan LB, Fabré VC, Caughman SW, Swerlick RA, Korman NJ, Callen JP. Paraneoplastic pemphigus in the absence of a known neoplasm. J Am Acad Dermatol 1995; 33: 312-315
70. Park GT, Lee JH, Yun SJ, Lee SC, Lee JB. Paraneoplastic pemphigus without an underlying neoplasm. Br J Dermatol 2007; 156: 563-566
71. Nguyen VT, Ndoye A, Bassler KD, Shultz LD, Shields MC, Ruben BS, Webber RJ, Pittelkow MR, Lynch PJ, Grando SA. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. Arch Dermatol 2001; 137: 193-206 (Pubitemid 32163671)
72. Jeghers H, McKusick VA, Katz KH. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance. N Engl J Med 1949; 241: 993, illust; passim
73. Sanchez-Cespedes M. A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome. Oncogene 2007; 26: 7825-7832 (Pubitemid 350261789)
74. Dourmishev A. Disorders of the Skin Pigmentation. Sofia: Med Fizk Publications House, 1986: 79 (in Bulgarian)
75. Shivaswamy KN, Shyamprasad AL, Sumathy TK, Ranganathan C. Peutz-Jeghers syndrome with prominent palmoplantar pigmentation. Indian J Dermatol Venereol Leprol 2008; 74: 154-155
76. Giardiello FM, Brensinger JD, Tersmette AC, Goodman SN, Petersen GM, Booker SV, Cruz-Correa M, Offerhaus JA. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000; 119: 1447-1453 (Pubitemid 32198669)
77. Cronkhite LW Jr, Canada WJ. Generalized gastrointestinal polyposis; an unusual syndrome of polyposis, pigmentation, alopecia and onychotrophia. N Engl J Med 1955; 252: 1011-1015
78. Allbritton J, Simmons-O'Brien E, Hutcheons D, Whitmore SE. Cronkhite-Canada syndrome: report of two cases, biopsy findings in the associated alopecia, and a new treatment option. Cutis 1998; 61: 229-232 (Pubitemid 128472609)
79. Gomes da Cruz GM. Generalized gastrointestinal polyposis. An unusual syndrome of adenomatous polyposis, alopecia, onychorotrophia. Am J Gastroenterol 1967; 47: 504-510
80. Yashiro M, Kobayashi H, Kubo N, Nishiguchi Y, Wakasa K, Hirakawa K. Cronkhite-Canada syndrome containing colon cancer and serrated adenoma lesions. Digestion 2004; 69: 57-62 (Pubitemid 38332926)
81. de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004; 4: 769-780
82. Samoha S, Arber N. Cronkhite-Canada syndrome. Digestion 2005; 71: 199-200
83. Turner M. Case of a woman whose face and body in two or three weeks' time became covered with a thick crop of short and white downy hair. Med Time Gaz 1865; 2: 507
84. Brinkmann J, Breier B, Goos M. [Hypertrichosis lanuginosa acquisita in ulcerative colitis with colon cancer] Hautarzt 1992; 43: 714-716
85. Slee PH, van der Waal RI, Schagen van Leeuwen JH, Tupker RA, Timmer R, Seldenrijk CA, van Steensel MA. Paraneoplastic hypertrichosis lanuginosa acquisita: uncommon or overlooked? Br J Dermatol 2007; 157: 1087-1092 (Pubitemid 350115709)
86. Wendelin DS, Pope DN, Mallory SB. Hypertrichosis. J Am Acad Dermatol 2003; 48: 161-179; quiz 180-181